Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

Amdl (ADL)

Amdl,
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:ADL
DateTimeSourceHeadlineSymbolCompany
10/12/201813:31GlobeNewswire Inc.Edison issues initiation on ADL Bionatur Solutions (BNT)AMEX:ADLAmdl,
10/12/201813:30GlobeNewswire Inc.Amyris and ADL Bionatur Solutions Expand Production Agreement to Meet Growing DemandAMEX:ADLAmdl,
18/09/200919:32Edgar (US Regulatory)Current report filing (8-K)AMEX:ADLAmdl,
18/09/200914:30PR Newswire (US)AMDL Inc. Announces Stockholder Approval of Name Change and Issuance of a New Trading Symbol on the NYSE Alternext USLSE:ADL
20/08/200914:49PR Newswire (US)AMDL Inc. Announces Inauguration of AMDL Diagnostics, Inc.LSE:ADL
19/08/200922:30PR Newswire (US)AMDL Inc. Announces Second Quarter 2009 Financial ResultsLSE:ADL
19/08/200922:23Edgar (US Regulatory)Quarterly Report (10-Q)AMEX:ADLAmdl,
14/08/200921:10Edgar (US Regulatory)Notification that Quarterly Report will be submitted late (NT 10-Q)AMEX:ADLAmdl,
14/08/200921:00PR Newswire (US)AMDL Inc. Files Notification of Late Filing for Form 10-QLSE:ADL
22/07/200914:30PR Newswire (US)AMDL Diagnostics Inc. Presenting at the AACC Annual Meeting and Clinical Lab Expo in Chicago, July 20-23, 2009LSE:ADL
08/07/200915:00PR Newswire (US)AMDL Inc. Introduces New Brand Name for Its DR-70 (FDP) In Vitro Diagnostic Cancer TestLSE:ADL
06/07/200911:04Edgar (US Regulatory)Revised Proxy Soliciting Materials (definitive) (DEFR14A)AMEX:ADLAmdl,
06/07/200911:04Edgar (US Regulatory)Proxy Statement (definitive) (DEF 14A)AMEX:ADLAmdl,
25/06/200922:30Edgar (US Regulatory)Proxy Soliciting Materials (revised) (PRER14A)AMEX:ADLAmdl,
23/06/200917:08Edgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(4) (424B4)AMEX:ADLAmdl,
17/06/200914:30PR Newswire (US)AMDL CEO Featured in CEOCFO Magazine; Details Progress on DR-70 International Commercialization Strategy & Confidence in FY2009 LSE:ADL
15/06/200922:33PR Newswire (US)AMDL Inc. Announces Second Closing of Private Placement of Series 2 Senior NotesLSE:ADL
15/06/200921:22Edgar (US Regulatory)Current report filing (8-K)AMEX:ADLAmdl,
11/06/200919:39Edgar (US Regulatory)Securities Registration Statement (simplified form) (S-3/A)AMEX:ADLAmdl,
15/05/200923:10PR Newswire (US)AMDL, Inc. Announces First Quarter 2009 Financial ResultsLSE:ADL
15/05/200921:59Edgar (US Regulatory)Securities Registration Statement (simplified form) (S-3)AMEX:ADLAmdl,
15/05/200921:52Edgar (US Regulatory)Quarterly Report (10-Q)AMEX:ADLAmdl,
13/05/200923:00PR Newswire (US)AMDL, Inc. Enters Into Distribution Agreements With GenWay Biotech, Inc. to Advance Commercialization of the DR-70 (FDP) CancerLSE:ADL
08/05/200914:30PR Newswire (US)AMDL Inc.'s JJB Plant Receives Production Approval From Chinese State Food and Drug Administration (SFDA)LSE:ADL
07/05/200917:30Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (D)AMEX:ADLAmdl,
06/05/200920:51PR Newswire (US)AMDL Inc. Announces First Closing of Private Placement of 12% Series Two Senior NotesLSE:ADL
06/05/200920:07Edgar (US Regulatory)Current report filing (8-K)AMEX:ADLAmdl,
30/04/200914:30PR Newswire (US)AMDL, Inc. Signs First Customer Agreement With Precision Diagnostic Laboratory for DR-70 (FDP) Cancer TestLSE:ADL
29/04/200914:30PR Newswire (US)Chinese Pharma Market Continues to Grow at a 5-7% Rate in 2009; AMDL Remains on Track to Meet FY09 Financial TargetsLSE:ADL
15/04/200922:58PR Newswire (US)AMDL, Inc. Reports 2008 Year End Financial Results and Fiscal Year 2009 Financial TargetsLSE:ADL
 Showing the most relevant articles for your search:AMEX:ADL